Eighteen million years ago, a genetic duplication event coincided with the evolutionary split between horses and their four-toed, forest-browsing ancestors.
Congratulations to Veterinary Scientist Training Program (VSTP) students Jenn Cossaboon, Chase Garcia, Erin Hisey, and Aryana Razmara for receiving prestigious National Institutes of Health (NIH) F30/F31 awards.
Veterinary medicine continues to find commonalities among conditions that affect animals and humans. This week, Dr. Monica Aleman presented an overview at the Platinum Summit in San Antonio of Juvenile Idiopathic Epilepsy (JIE) in Egyptian Arabian foals—an epileptic syndrome similar to one found in infants.
Two house officer veterinarians with the UC Davis School of Veterinary Medicine (SVM) were recently named the inaugural recipients of the Outstanding American Journal of Veterinary Research (AJVR) Resident Manuscript Awards.
The lowering of dietary recommendations for the consumption of free or added sugar from 25% to 10% of daily calories has been criticized as being based on low-quality scientific evidence, ill-informed opinions and over-extrapolation of results from studies on sugar-sweetened beverages. This Comment by Dr. Kimber Stanhope rebuts these criticisms.
Infant monkeys conceived while their mothers were naturally exposed to wildfire smoke show behavioral changes compared to animals conceived days later, according to a new UC Davis study.
A study led by the University of California, Davis, has found significant differences in gut bacteria between Black and white women, even after accounting for their insulin sensitivity status.
Over the past several years molecular geneticists have been researching the application of CRISPR-Cas9 gene editing technology to mosquitoes that transmit malaria.
On August 5, UC Davis veterinary radiologist Dr. Mathieu Spriet presented "New Equine Imaging Options with Standing PET at UC Davis," an informative webinar to update veterinarians on the latest in positron emission tomography (PET) for horses.
UC Davis veterinarians have found that a cat’s DNA alters how it responds to a life-saving medication used to treat hypertrophic cardiomyopathy, a heart disease that affects 1 in 7 cats.
